-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

627.O3.6 627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PCNSL Treatment and Prognosis and CNS Prophylaxis in High-Risk Aggressive Lymphomas

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, antibodies, Diseases, Non-Biological, Elderly, Therapies, Combinations, Non-Hodgkin Lymphoma, CNS Lymphoma, chemotherapy, DLBCL, B-Cell Lymphoma, immunotherapy, Study Population, Lymphoid Malignancies, Clinically relevant
Sunday, December 6, 2020: 2:00 PM-3:30 PM
Moderators:
Toby A. Eyre, Oxford University Hospitals NHS Foundation Trust and Jonathon B. Cohen, MD, MS, Emory University
Disclosures:
Cohen: Janssen, Adicet, Astra Zeneca, Genentech, Aptitude Health, Cellectar, Kite/Gilead, Loxo: Consultancy; Genentech, BMS, Novartis, LAM, BioInvent, LRF, ASH, Astra Zeneca, Seattle Genetics: Research Funding.
2:00 PM

Kevin A. David, MD 1, Suchitra Sundaram, MD2*, Seo-Hyun Kim, MD3, Ryan Vaca, MD4, Yong Lin, PhD1*, Samuel Singer, MD5*, Mary-Kate Malecek, MD6, Jordan Carter, MD1*, Adam Zayac, MD7, Myung Sun Kim, MD8*, Nishitha Reddy, MD9, Alma Habib, MD10*, Christopher Strouse, MD11, Jerome Graber, MD12*, Veronika Bachanova, MD, PhD13, Mazie Tsang, MD14, Ajay Major, MD, MBA15, David A. Bond, MD, BS16, Prashasti Agrawal17*, Angel Mier-Hicks, MD18, Pallawi Torka, MD19, Priya Rajakumar, MD20*, Parameswaran Venugopal, MD21, Michael Glantz, MD, PhD22*, Samuel Goldlust, MD23*, Rahul Matnani, MD24*, Pallavi Kumar, MD25*, Thomas A Ollila, MD26, Johnny Cai, DO27*, Stephen E. Spurgeon, MD28, Alex G Sieg, MD, MS29*, Joseph Cleveland, MD30*, Narendranath Epperla, MD, MS31, Reem Karmali, MD, MSc32, Seema Naik, MD33*, Peter Martin, FRCPC, MD, MS34, Sonali M. Smith, MD35, James L. Rubenstein, MD, PhD14, Brad S. Kahl, MD36 and Andrew M. Evens, DO, MMSc1

1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
2Roswell Park, Buffalo, NY
3Rush University Medical Center, Chicago, IL
4Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA
5John Theurer Cancer Center, Hackensack, NJ
6Department of Medicine, Washington University School of Medicine, University City, MO
7Department of Medicine, Alpert Medical School of Brown University, Providence, RI
8Knight Cancer Institute, Oregon Health and Science University, Portland, OR
9Vanderbilt University Medical Center, Nashville, TN
10University of Minnesota School of Medicine, Minneapolis, MN
11Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
12University of Washington, Seattle, WA
13Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
14Hematology/Oncology, UCSF, San Francisco, CA
15Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
16Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
17Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
18Roswell Park Comprehensive Cancer Center, Buffalo, NY
19Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
20Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL
21Division of Hematology Oncology, Rush University Medical Center, Chicago, IL
22Department of Neurosurgery, Penn State College of Medicine, Hershey, PA
23John Theurer Cancer Center, Hackensack-Meridian Health, Hackensack, NJ
24Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
25Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
26Brown University, Providence, RI
27Oregon Health and Science University, Portland, OR
28Oregon Health & Science University, Portland, OR
29Department of Internal Medicine, University of Iowa, Iowa City, IA
30University of California, San Francisco, San Francisco, CA
31The Ohio State University James Comprehensive Cancer Center, Columbus, OH
32Division of Hematology Oncology, Northwestern University, Chicago, IL
33Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA
34Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY
35Department of Oncology, University of Chicago, Chicago, IL
36Washington University School of Medicine in St. Louis, Saint Louis, MO

2:15 PM

Robert Puckrin, MD1, Haidar El Darsa, MD2*, Sunita Ghosh, PhD, P Stat3*, Anthea Peters, MSc, MD, FRCPC4 and Douglas A. Stewart, MD, FRCPC5

1University of Calgary, Toronto, ON, Canada
2University of Alberta, Edmonton, AB, Canada
3Cross Cancer Institute, Edmonton, AB, Canada
4Department of Oncology, University of Alberta/Cross Cancer Institute, Edmonton, AB, Canada
5Department of Oncology, University of Calgary/Tom Baker Cancer Centre, Calgary, AB, Canada

2:30 PM

Victor M. Orellana-Noia, MD1, Daniel R Reed, MD2, Jeremy M Sen, PharmD, BCOP3*, Christian Barlow, MD4, Mary-Kate Malecek, MD5, Brad S. Kahl, MD6, Michael A Spinner, MD7, Ranjana Advani, MD8, Timothy J Voorhees, MD9, Anson Snow, MD10, Natalie S Grover, MD9, Amy Ayers, MPH1*, Jason T. Romancik, MD11, Yuxin Liu, MD12*, Scott F. Huntington, MD, MPH12, Julio C. Chavez, MD13, Hayder Saeed, MD14, Aleksandr Lazaryan, MD, PhD, MPH15, Vikram Raghunathan, MD16*, Stephen E. Spurgeon, MD17, Thomas A Ollila, MD18, Christopher Del Prete, MD18*, Adam J Olszewski, MD18, Emily C. Ayers, MD19, Daniel J. Landsburg, MD20, Benjamin Echalier21*, Jun Lee21*, Manali Kamdar, MD22, Paolo F Caimi, MD23, Timothy Fu, MD24*, Jieqi Liu, MD25*, Kevin A. David, MD 26, Hanan Alharthy, MD27*, Jennie Y. Law, MD28, Reem Karmali, MD, MSc29, Harsh Shah, DO30, Deborah M. Stephens, DO31, Ajay Major, MD, MBA32, Alexandra E Rojek, MD33*, Sonali M. Smith, MD34, Amulya Yellala, MBBS35, Avyakta Kallam, MD36, Shazia Nakhoda, MD37, Nadia Khan, MD37, Jonathon B. Cohen, MD, MS38 and Craig A. Portell, MD39

1Winship Cancer Institute, Emory University, Atlanta, GA
2Division of Hematology/Oncology, Wake Forest University, Winston-Salem, NC
3Department of Pharmacy Services, University of Virginia, Charlottesville, VA
4Division of Hematology and Oncology, University of Virginia, Charlottesville, VA
5Department of Medicine, Washington University School of Medicine, University City, MO
6Division of Medical Oncology, Washington University School of Medicine, Saint Louis, MO
7Division of Oncology, Department of Medicine, Stanford University, Stanford, CA
8Division of Oncology, Department of Medicine, Saul A. Rosenberg Professor of Lymphoma, Stanford Cancer Institute, Stanford, CA
9Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
10University of North Carolina, Chapel Hill, NC
11Department of Hematology and Medical Oncology, Emory University - Winship Cancer Institute, Atlanta, GA
12Yale University, New Haven, CT
13Division of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL
14H. Lee Moffitt Cancer Center, Tampa, FL
15Hematology, Oncology and Transplantation, Moffitt Cancer Center, Tampa, FL
16Division of Hematology and Oncology, Oregon Health Sciences University, Portland, OR
17Oregon Health & Science University, Portland, OR
18Brown University, Providence, RI
19Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA
20Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
21University of Colorado, Aurora, CO
22Division of Hematology, University of Colorado, Denver, CO
23Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
24Rutgers University, Newark, NJ
25Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ
26Cancer Institute of New Jersey, New Brunswick, NJ
27University of Maryland, Baltimore, MD
28Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
29Division of Hematology Oncology, Northwestern University, Chicago, IL
30University of Utah/ Huntsman Cancer Center, Salt Lake City, UT
31University of Utah/Huntsman Cancer Institute, Salt Lake City, UT
32Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
33Department of Medicine, University of Chicago, Chicago, IL
34Department of Oncology, University of Chicago, Chicago, IL
35Department of Hematology and Oncology, University Of Nebraska Medical Center, Omaha, NE
36University of Nebraska Medical Center, Omaha, NE
37Fox Chase Cancer Center, Philadelphia, PA
38Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
39Division of Hematology/Oncology, University of Virginia, Charlottesville, VA

*signifies non-member of ASH